Center for Healthcare Ethics, McAnulty College and Graduate School of Liberal Arts, Duquesne University, Pittsburgh, PA.
Division of Plastic and Hand Surgery, University Hospital Zurich, Zurich, Switzerland.
Transplantation. 2019 Sep;103(9):1746-1751. doi: 10.1097/TP.0000000000002606.
Early results of hand and face transplants and other grafts such as those of uterus, penis, trachea, larynx, or abdominal wall have confirmed the potential for vascularized composite allotransplantation (VCA) to restore appearance, anatomy, function, independence, and social integration in patients suffering from devastating tissue deficits untreatable by conventional treatment options. Despite such promise, these novel and complex procedures face challenges and controversies that remain open to discussion and debate. Indeed, many barriers to clinical advancement and negative stakeholder perceptions still exist. The bioethical challenges surrounding VCA include but are not limited to justice and vulnerability of subjects, and their experiences with risks, benefits and outcomes, provider economy of fame, public awareness and attitudes toward transplantation, and policy and regulatory issues shaping progress of the field. The First International Workshop on Bioethical Challenges in Reconstructive Transplantation was organized by the Brocher Foundation in Hermance, Switzerland. VCA professionals representing teams from across the world examined bioethical issues in VCA related to standards for safety, efficacy, feasibility, privacy, confidentiality, and equitability. Key discussion topics from the workshop were included in a survey questionnaire implemented across VCA professionals attending the 13th Congress of International Society of VCA held in Salzburg, Austria. The insights from the Brocher workshop and International Society of VCA survey as presented here could help inform the future development of clinical practice and policy strategies in VCA to ensure value, accessibility, and acceptance of these procedures by potential donors, potential or actual recipients and their families, and providers and payers.
手部和面部移植以及其他移植物(如子宫、阴茎、气管、喉头或腹壁)的早期结果证实,血管化复合组织同种异体移植(VCA)有可能恢复因常规治疗方法无法治疗的严重组织缺损的患者的外观、解剖结构、功能、独立性和社会融合。尽管有这样的前景,但这些新颖而复杂的程序仍然面临挑战和争议,这些挑战和争议仍有待讨论和辩论。事实上,许多临床进展的障碍和负面利益相关者的看法仍然存在。VCA 所涉及的生物伦理挑战包括但不限于受试者的公正和脆弱性,以及他们对风险、收益和结果的体验、提供者的声誉经济、公众对移植的认识和态度,以及政策和监管问题塑造了该领域的进展。第一届重建性移植生物伦理挑战国际研讨会由瑞士赫尔芒斯的布罗赫基金会组织。来自世界各地的 VCA 专业人员代表团队,审查了与安全性、有效性、可行性、隐私、保密性和公平性相关的 VCA 中的生物伦理问题。该研讨会的重点讨论议题被纳入了一项问卷调查,该调查面向参加在奥地利萨尔茨堡举行的第十三届国际 VCA 学会大会的 VCA 专业人员。这里介绍的布罗赫研讨会和国际 VCA 学会调查的见解可以帮助为 VCA 的临床实践和政策战略的未来发展提供信息,以确保这些程序得到潜在供体、潜在或实际接受者及其家属以及提供者和支付者的重视、可及性和接受。